Lv1
50 积分 2024-03-24 加入
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
22小时前
待确认
The evolution of commercial drug delivery technologies
19天前
已完结
CD3ɛ Nanobody‐Engineered Extracellular Vesicles Driving In Vivo Generation of BiTE‐Secreting CAR‐Ts for Solid Tumor Therapy With Memory Response and Minimal Immunogenicity
23天前
已完结
Translating synthetic gene circuits into the clinic: Challenges, opportunities, and future directions
24天前
已完结
Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers
1个月前
已完结
Targeted delivery of genome editors in vivo
1个月前
已完结
Promoting Tag Removal of a MBP-Fused Integral Membrane Protein by TEV Protease
1个月前
已完结
Intratumoural vaccination via checkpoint degradation-coupled antigen presentation
1个月前
已完结
In vivo expression of CD3/CD19 bispecific T-cell engager and α-PD-L1-Fc enables effective and durable immunotherapy for CD19+/PD-L1+ leukemia
1个月前
已完结
Target antigen–displaying extracellular vesicles boost CAR T cell efficacy in cell and mouse models of neuroblastoma
1个月前
已完结
皖公网安备34019202002308
